Strategic Partnerships Qnostics has a history of collaboration with large players like Randox, indicating openness to partnership-based distribution and co-development. This presents an opportunity to position joint solutions or exclusive distribution deals to expand market reach in infectious disease molecular controls.

Global Reach With manufacturing in the UK, commercial offices in the UK and US, and a network of international distribution partners, there is potential to target multinational laboratories, CROs, and IVDs in North America and Europe for updated or new molecular control products.

Custom Solutions Qnostics specializes in custom manufactured molecular controls across R&D to on-market support. This suggests a sales angle around bespoke control materials, feeder products, and QA/QC bundles tailored to specific assay platforms and regulatory requirements.

Infectious Disease Focus Primary emphasis on infectious disease controls with hundreds of characterized targets. Opportunities exist to upsell expanded panels, validation kits, or reference materials aligned with emerging pathogens and evolving diagnostic assays.

Mid-market Potential Reported revenue in the lower-to-mid tens of millions with a small to mid-sized workforce signals buyers who value flexible, responsive service. This can be leveraged to position Qnostics as a cost-effective, agile supplier for mid-sized IVD labs, who may seek reliable custom controls and quick onboarding.